IC
JAZZ icon

IEQ Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

IEQ Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$398K Sell
1,651
-2,137
-56% -$468K ﹤0.01% 1511
2026
Q1 		$716K Buy
3,788
+646
+21% +$113K ﹤0.01% 1155
2025
Q4 		$534K Buy
+3,142
New +$482K ﹤0.01% 1304
2025
Q3 		– Sell
-3,970
Closed -$421K – 1966
2025
Q2 		$421K Buy
+3,970
New +$431K ﹤0.01% 1242

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

IEQ Capital's JAZZ Position: Q2 2026 in Review

IEQ Capital reduced its Jazz Pharmaceuticals (JAZZ) stake by 56% in Q2 2026, selling an estimated $468K and leaving 1,651 shares worth $398K. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

IEQ Capital first reported a position in JAZZ in Q2 2025 and has held it in 4 quarters since. The position peaked at $716K in Q1 2026. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • IEQ Capital held 1,651 shares of Jazz Pharmaceuticals worth $398K as of Q2 2026.
  • IEQ Capital sold 2,137 Jazz Pharmaceuticals shares in Q2 2026, an estimated $468K.
  • Jazz Pharmaceuticals made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1511 holding.
  • IEQ Capital first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • IEQ Capital's Jazz Pharmaceuticals position peaked at $716K in Q1 2026.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.